The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2V617F Mutation

OBJECTIVE: The prefibrotic stages of JAK2V617F essential thrombocythemia (ET) and JAK2V617F polycythemia vera (PV) can easily be diagnosed clinically without use of bone marrow biopsy histology. We assessed the 2008 WHO and European Clinical, Molecular, and Pathological (ECMP) criteria for the diagn...

Descrición completa

Detalles Bibliográficos

Principais autores:	Jan Jacques Michiels, Fibo Ten Kate, King H. Lam, Wilfried Schroyens, Zwi Berneman, Hendrik De Raeve
Formato:	Artigo
Idioma:	Inglês
Publicado:	Turkish Society of Hematology 2014-08-01
Series:	Turkish Journal of Hematology
Assuntos:	myeloproliferative disorders myeloproliferative neoplasm essential thrombocythemia polycythemia vera primary myelofibrosis jak2v617f mutation bone marrow histopathology red cell mass erythrocyte count
Acceso en liña:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-78476
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!